| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0005 |